Alleviation of isolated nail lichen planus by the JAK1/2 inhibitor Baricitinib: a case report

Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis

(2021) Matilde Iorizzo et al.   JAMA Dermatology

Review of Nail Lichen Planus

(2021) Mohit Kumar Gupta et al.   DERMATOLOGIC CLINICS

Treatment of Severe Nail Lichen Planus With Baricitinib

(2021) Jöri Pünchera et al.   JAMA Dermatology

Lichen Planus

(2021) Katharina Boch et al.   Frontiers in Medicine

Treatment of severe lichen planus with the JAK inhibitor tofacitinib

(2020) William Damsky et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Tofacitinib in the treatment of lichen planopilaris: a retrospective review

(2020) John Plante et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus

(2019) Shuai Shao et al.   Science Translational Medicine

Emerging Topical and Systemic JAK Inhibitors in Dermatology

(2019) Farzan Solimani et al.   Frontiers in Immunology

Tofacitinib for the treatment of lichen planopilaris: A case series

(2018) Christine C. Yang et al.   Dermatologic Therapy

Lichen planus and lichenoid dermatoses

(2018) Christos Tziotzios et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Targeting the IFN-γ/CXCL10 pathway in lichen planus

(2016) Vito Di Lernia   MEDICAL HYPOTHESES

Nail lichen planus: epidemiological, clinical, pathological, therapeutic and prognosis study of 67 cases

(2011) S. Goettmann et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY